Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Computer-assisted Risk Evaluation in the Early Detection of Psychotic Disorders

NCT: NCT05813080 · COMPLETED

NCT IDNCT05813080
StatusCOMPLETED
Start Date2023-05-01
Completion2025-12-16
SponsorHeinrich-Heine University, Duesseldorf (OTHER)
First posted
Last updated

Brief Summary

Multicenter randomized controlled trial (RCT) with artificial intelligence (AI)-staged early diagnostics and risk-adapted treatment (RAB) as interventional treatment arm and treatment-as-usual (TAU) as control treatment arm for patients with an increased clinical risk for psychosis.

Frequently Asked Questions

What is Computer-assisted Risk Evaluation in the Early Detection of Psychotic Disorders?

Computer-assisted Risk Evaluation in the Early Detection of Psychotic Disorders is a clinical trial registered under NCT05813080. Current status: COMPLETED.

What is the status of NCT05813080?

The current status of NCT05813080 (Computer-assisted Risk Evaluation in the Early Detection of Psychotic Disorders) is: COMPLETED.

When did Computer-assisted Risk Evaluation in the Early Detection of Psychotic Disorders start?

Computer-assisted Risk Evaluation in the Early Detection of Psychotic Disorders started on 2023-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.